PD-L(1) checkpoint inhibitor Stakeholder Meeting Outcome Statement

The Outcome Statement for the PD-(L)1 checkpoint inhibitor Stakeholder Meeting held on  8 February 2019 , discussing the option for a broad PBS subsidy listing for PD-(L)1 inhibitors for non-small cell lung is now available.